B. Riley Wealth Advisors Inc. decreased its place in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 30.9% in the course of the second quarter, in response to its most up-to-date 13F submitting with the Securities and Trade Fee (SEC). The agency owned 11,072 shares of the corporate’s inventory after promoting 4,944 shares in the course of the quarter. B. Riley Wealth Advisors Inc.’s holdings in Zoetis had been value $1,919,000 as of its most up-to-date SEC submitting.
Quite a few different hedge funds and different institutional buyers have additionally made modifications to their positions in ZTS. Ecofi Investissements SA acquired a brand new stake in Zoetis in the course of the second quarter valued at $5,541,000. Wallace Capital Administration Inc. boosted its stake in shares of Zoetis by 8.2% in the course of the 2nd quarter. Wallace Capital Administration Inc. now owns 3,972 shares of the corporate’s inventory value $689,000 after buying an extra 300 shares within the final quarter. Quarry LP grew its place in shares of Zoetis by 273.2% in the course of the 2nd quarter. Quarry LP now owns 209 shares of the corporate’s inventory valued at $36,000 after buying an extra 153 shares in the course of the interval. Wallace Advisory Group LLC elevated its stake in shares of Zoetis by 37.8% within the 2nd quarter. Wallace Advisory Group LLC now owns 4,476 shares of the corporate’s inventory valued at $776,000 after buying an extra 1,228 shares within the final quarter. Lastly, Wellington Wealth Methods LLC. bought a brand new place in shares of Zoetis within the 2nd quarter valued at about $248,000. Institutional buyers and hedge funds personal 92.80% of the corporate’s inventory.
Analysts Set New Value Targets
ZTS has been the subject of a number of analysis analyst studies. BTIG Analysis raised their worth goal on Zoetis from $220.00 to $225.00 and gave the corporate a “purchase” ranking in a report on Monday, August twelfth. Piper Sandler lifted their worth goal on shares of Zoetis from $195.00 to $210.00 and gave the corporate an “obese” ranking in a analysis observe on Wednesday, August 14th. Argus raised shares of Zoetis to a “strong-buy” ranking in a report on Friday, August ninth. Lastly, Stifel Nicolaus boosted their goal worth on shares of Zoetis from $200.00 to $210.00 and gave the inventory a “purchase” ranking in a analysis observe on Wednesday, September 18th. 9 analysts have rated the inventory with a purchase ranking and one has issued a powerful purchase ranking to the inventory. In accordance with MarketBeat, the corporate presently has a consensus ranking of “Purchase” and a consensus goal worth of $220.38.
View Our Newest Inventory Evaluation on ZTS
Zoetis Value Efficiency
Shares of NYSE ZTS opened at $192.49 on Thursday. The agency has a 50-day easy shifting common of $186.89 and a 200-day easy shifting common of $175.21. The corporate has a fast ratio of two.09, a present ratio of three.45 and a debt-to-equity ratio of 1.32. The inventory has a market capitalization of $87.83 billion, a price-to-earnings ratio of 37.09, a price-to-earnings-growth ratio of two.99 and a beta of 0.88. Zoetis Inc. has a 52 week low of $144.80 and a 52 week excessive of $201.92.
Zoetis (NYSE:ZTS – Get Free Report) final launched its quarterly earnings information on Tuesday, August sixth. The corporate reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. The corporate had income of $2.36 billion in the course of the quarter, in comparison with the consensus estimate of $2.31 billion. Zoetis had a web margin of 26.29% and a return on fairness of fifty.67%. Zoetis’s quarterly income was up 8.3% on a year-over-year foundation. Throughout the identical quarter within the prior 12 months, the agency earned $1.41 EPS. On common, equities analysts predict that Zoetis Inc. will publish 5.84 earnings per share for the present fiscal 12 months.
Zoetis Firm Profile
Zoetis Inc engages within the discovery, growth, manufacture, and commercialization of animal well being medicines, vaccines, and diagnostic services and products in the USA and internationally. The corporate commercializes merchandise primarily throughout species, together with livestock, corresponding to cattle, swine, poultry, fish, and sheep and others; and companion animals comprising canine, cats, and horses.
Really useful Tales
Need to see what different hedge funds are holding ZTS? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Obtain Information & Rankings for Zoetis Each day – Enter your e mail deal with beneath to obtain a concise each day abstract of the most recent information and analysts’ scores for Zoetis and associated corporations with MarketBeat.com’s FREE each day e mail e-newsletter.
